ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $62,000 | +37.8% | 36,600 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | -13.5% | 36,600 | 0.0% | 0.00% | – |
| Q3 2020 | $52,000 | -38.8% | 36,600 | -48.2% | 0.00% | – |
| Q2 2020 | $85,000 | +107.3% | 70,600 | +104.6% | 0.00% | – |
| Q1 2020 | $41,000 | -8.9% | 34,500 | +61.2% | 0.00% | – |
| Q4 2019 | $45,000 | -4.3% | 21,400 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | -13.0% | 21,400 | 0.0% | 0.00% | – |
| Q2 2019 | $54,000 | -1.8% | 21,400 | +50.7% | 0.00% | – |
| Q1 2015 | $55,000 | +14.6% | 14,200 | +97.2% | 0.00% | – |
| Q4 2014 | $48,000 | -35.1% | 7,200 | -46.3% | 0.00% | – |
| Q3 2014 | $74,000 | -46.0% | 13,400 | 0.0% | 0.00% | – |
| Q2 2014 | $137,000 | – | 13,400 | +60809.1% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 22 | -97.3% | 0.00% | – |
| Q4 2013 | $9,000 | -96.2% | 822 | -96.3% | 0.00% | – |
| Q3 2013 | $239,000 | +8.1% | 22,222 | -6.6% | 0.00% | – |
| Q2 2013 | $221,000 | – | 23,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |